Industry: Medical Devices & Consumables
Published Date: 2025-01-16
Pages: 87 Pages
Report ld: 3481456
Request Sample
Customized Report
Bone Morphogenetic Protein (BMP) Market Size(US$)

CAGR 2025-2031
9.1%
Market Size,2031
USD 1,284
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Human recombinant BMP7 has surgical uses and was originally marketed under the brand name OP1 (Olympus Biotech, who bought it from Stryker). It can be used to aid in the fusion of vertebral bodies to prevent neurologic trauma. rhBMP-7 has withdrawn off the market. rhBMP-4 and rhBMP-6 do not have commercial product launched. Therefore, in this report, we only study the rhBMP-2.
Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.
The global core manufacturers of Bone Morphogenetic Protein (BMP) include Medtronic, Jiuyuan Gene Engineering and Cellumed. The top three companies have a market share of about 99%. North America is the largest global market for Bone Morphogenetic Protein (BMP) with a market share of approximately 69%, followed by Asia Pacific and Europe with a market share of 19% and 9%, respectively. In terms of application, Spinal Fusion is the largest downstream segment, accounting for approximately 73% of the market.
This report aims to provide a comprehensive presentation of the global market for Bone Morphogenetic Protein (BMP), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bone Morphogenetic Protein (BMP) by region & country, by Type, and by Application.
The Bone Morphogenetic Protein (BMP) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Morphogenetic Protein (BMP).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bone Morphogenetic Protein (BMP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bone Morphogenetic Protein (BMP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bone Morphogenetic Protein (BMP) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Bone Morphogenetic Protein (BMP) Product Introduction
1.2 Global Bone Morphogenetic Protein (BMP) Market Size Forecast
1.2.1 Global Bone Morphogenetic Protein (BMP) Sales Value (2020-2031)
1.2.2 Global Bone Morphogenetic Protein (BMP) Sales Volume (2020-2031)
1.2.3 Global Bone Morphogenetic Protein (BMP) Sales Price (2020-2031)
1.3 Bone Morphogenetic Protein (BMP) Market Trends & Drivers
1.3.1 Bone Morphogenetic Protein (BMP) Industry Trends
1.3.2 Bone Morphogenetic Protein (BMP) Market Drivers & Opportunity
1.3.3 Bone Morphogenetic Protein (BMP) Market Challenges
1.3.4 Bone Morphogenetic Protein (BMP) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bone Morphogenetic Protein (BMP) Players Revenue Ranking (2024)
2.2 Global Bone Morphogenetic Protein (BMP) Revenue by Company (2020-2025)
2.3 Global Bone Morphogenetic Protein (BMP) Players Sales Volume Ranking (2024)
2.4 Global Bone Morphogenetic Protein (BMP) Sales Volume by Company Players (2020-2025)
2.5 Global Bone Morphogenetic Protein (BMP) Average Price by Company (2020-2025)
2.6 Key Manufacturers Bone Morphogenetic Protein (BMP) Manufacturing Base and Headquarters
2.7 Key Manufacturers Bone Morphogenetic Protein (BMP) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bone Morphogenetic Protein (BMP)
2.9 Bone Morphogenetic Protein (BMP) Market Competitive Analysis
2.9.1 Bone Morphogenetic Protein (BMP) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Bone Morphogenetic Protein (BMP) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bone Morphogenetic Protein (BMP) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sponge Carrier
3.1.2 Hydroxyapatite Carrier
3.2 Global Bone Morphogenetic Protein (BMP) Sales Value by Type
3.2.1 Global Bone Morphogenetic Protein (BMP) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Bone Morphogenetic Protein (BMP) Sales Value, by Type (2020-2031)
3.2.3 Global Bone Morphogenetic Protein (BMP) Sales Value, by Type (%) (2020-2031)
3.3 Global Bone Morphogenetic Protein (BMP) Sales Volume by Type
3.3.1 Global Bone Morphogenetic Protein (BMP) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Bone Morphogenetic Protein (BMP) Sales Volume, by Type (2020-2031)
3.3.3 Global Bone Morphogenetic Protein (BMP) Sales Volume, by Type (%) (2020-2031)
3.4 Global Bone Morphogenetic Protein (BMP) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Spinal Fusion
4.1.2 Trauma Surgery
4.1.3 Oral Maxillofacial Surgery
4.1.4 Reconstructive
4.2 Global Bone Morphogenetic Protein (BMP) Sales Value by Application
4.2.1 Global Bone Morphogenetic Protein (BMP) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Bone Morphogenetic Protein (BMP) Sales Value, by Application (2020-2031)
4.2.3 Global Bone Morphogenetic Protein (BMP) Sales Value, by Application (%) (2020-2031)
4.3 Global Bone Morphogenetic Protein (BMP) Sales Volume by Application
4.3.1 Global Bone Morphogenetic Protein (BMP) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Bone Morphogenetic Protein (BMP) Sales Volume, by Application (2020-2031)
4.3.3 Global Bone Morphogenetic Protein (BMP) Sales Volume, by Application (%) (2020-2031)
4.4 Global Bone Morphogenetic Protein (BMP) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Bone Morphogenetic Protein (BMP) Sales Value by Region
5.1.1 Global Bone Morphogenetic Protein (BMP) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Bone Morphogenetic Protein (BMP) Sales Value by Region (2020-2025)
5.1.3 Global Bone Morphogenetic Protein (BMP) Sales Value by Region (2026-2031)
5.1.4 Global Bone Morphogenetic Protein (BMP) Sales Value by Region (%), (2020-2031)
5.2 Global Bone Morphogenetic Protein (BMP) Sales Volume by Region
5.2.1 Global Bone Morphogenetic Protein (BMP) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Bone Morphogenetic Protein (BMP) Sales Volume by Region (2020-2025)
5.2.3 Global Bone Morphogenetic Protein (BMP) Sales Volume by Region (2026-2031)
5.2.4 Global Bone Morphogenetic Protein (BMP) Sales Volume by Region (%), (2020-2031)
5.3 Global Bone Morphogenetic Protein (BMP) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
5.4.2 North America Bone Morphogenetic Protein (BMP) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
5.5.2 Europe Bone Morphogenetic Protein (BMP) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
5.6.2 Asia Pacific Bone Morphogenetic Protein (BMP) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
5.7.2 South America Bone Morphogenetic Protein (BMP) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
5.8.2 Middle East & Africa Bone Morphogenetic Protein (BMP) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bone Morphogenetic Protein (BMP) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Bone Morphogenetic Protein (BMP) Sales Value
6.2.1 Key Countries/Regions Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Bone Morphogenetic Protein (BMP) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
6.3.2 United States Bone Morphogenetic Protein (BMP) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Bone Morphogenetic Protein (BMP) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
6.4.2 Europe Bone Morphogenetic Protein (BMP) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Bone Morphogenetic Protein (BMP) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
6.5.2 China Bone Morphogenetic Protein (BMP) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Bone Morphogenetic Protein (BMP) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
6.6.2 Japan Bone Morphogenetic Protein (BMP) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Bone Morphogenetic Protein (BMP) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
6.7.2 South Korea Bone Morphogenetic Protein (BMP) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Bone Morphogenetic Protein (BMP) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
6.8.2 Southeast Asia Bone Morphogenetic Protein (BMP) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Bone Morphogenetic Protein (BMP) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Bone Morphogenetic Protein (BMP) Sales Value, 2020-2031
6.9.2 India Bone Morphogenetic Protein (BMP) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Bone Morphogenetic Protein (BMP) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Bone Morphogenetic Protein (BMP) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Medtronic Bone Morphogenetic Protein (BMP) Product Offerings
7.1.5 Medtronic Recent Development
7.2 Jiuyuan Gene Engineering
7.2.1 Jiuyuan Gene Engineering Company Information
7.2.2 Jiuyuan Gene Engineering Introduction and Business Overview
7.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) Product Offerings
7.2.5 Jiuyuan Gene Engineering Recent Development
7.3 Cellumed
7.3.1 Cellumed Company Information
7.3.2 Cellumed Introduction and Business Overview
7.3.3 Cellumed Bone Morphogenetic Protein (BMP) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Cellumed Bone Morphogenetic Protein (BMP) Product Offerings
7.3.5 Cellumed Recent Development
8 Industry Chain Analysis
8.1 Bone Morphogenetic Protein (BMP) Industrial Chain
8.2 Bone Morphogenetic Protein (BMP) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bone Morphogenetic Protein (BMP) Sales Model
8.5.2 Sales Channel
8.5.3 Bone Morphogenetic Protein (BMP) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Bone Morphogenetic Protein (BMP) market size was US$ 760 million in 2025 and is forecast to reach a readjusted size of US$ 1389 million by 2032 with a CAGR of 9.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 74
USD 4250.00
(Single User License)
The global Bone Morphogenetic Protein (BMP) market was valued at US$ 760 million in 2025 and is anticipated to reach US$ 1389 million by 2032, at a CAGR of 9.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 102
USD 2900.00
(Single User License)
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 760 million in 2025 and is projected to reach US$ 1389 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 87
USD 3950.00
(Single User License)
The global Bone Morphogenetic Protein (BMP) market is projected to grow from US$ 703 million in 2024 to US$ 1284 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 119
USD 4900.00
(Single User License)
The global market for Bone Morphogenetic Protein (BMP) was valued at US$ 703 million in the year 2024 and is projected to reach a revised size of US$ 1284 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published Date: 2025-05-12
Pages: 75
USD 2900.00
(Single User License)
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-05-10
Pages: 84
USD 3950.00
(Single User License)
The global Bone Morphogenetic Protein (BMP) market is projected to grow from US$ 760 million in 2025 to US$ 1284 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period.
Published Date: 2025-05-10
Pages: 116
USD 4900.00
(Single User License)
The global Bone Morphogenetic Protein (BMP) market size was US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-05-10
Pages: 71
USD 4250.00
(Single User License)
In 2024, the global market size of Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million and is forecast to reach approximately US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 108
USD 5900.00
(Single User License)
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Published Date: 2024-05-27
Pages: 85
USD 4350.00
(Single User License)
The global Bone Morphogenetic Protein (BMP) market size was US$ 760 million in 2025 and is forecast to reach a readjusted size of US$ 1389 million by 2032 with a CAGR of 9.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 74
The global Bone Morphogenetic Protein (BMP) market was valued at US$ 760 million in 2025 and is anticipated to reach US$ 1389 million by 2032, at a CAGR of 9.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 102
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 760 million in 2025 and is projected to reach US$ 1389 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 87
The global Bone Morphogenetic Protein (BMP) market is projected to grow from US$ 703 million in 2024 to US$ 1284 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 119
The global market for Bone Morphogenetic Protein (BMP) was valued at US$ 703 million in the year 2024 and is projected to reach a revised size of US$ 1284 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published: 2025-05-12
Pages: 75
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-05-10
Pages: 84
The global Bone Morphogenetic Protein (BMP) market is projected to grow from US$ 760 million in 2025 to US$ 1284 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period.
Published: 2025-05-10
Pages: 116
The global Bone Morphogenetic Protein (BMP) market size was US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-05-10
Pages: 71
In 2024, the global market size of Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million and is forecast to reach approximately US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 108
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Published: 2024-05-27
Pages: 85
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now